Page 6 - Global Growth Pharmaceuticals & Biotech Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Apr 11, 2026

Discover Global Pharmaceuticals & Biotech Growth Stocks from around the world. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

3,009 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
CAI	US$18.05	-6.4%	n/a	US$5.1b	US$31.00	6.3	69.6%	n/a
SRRA	US$54.99	0.06%	179.4%	US$1.3b	US$55.00	5.1	69.5%	n/a
IOVA	US$3.70	7.9%	12.1%	US$1.5b	US$9.00	5.8	69.5%	n/a
RNXT	US$0.99	0.5%	27.6%	US$44.4m	US$6.88	39.5	69.3%	n/a
EDT	CA$1.40	-1.4%	94.4%	CA$410.8m	CA$3.15	168.2	69.2%	n/a
DVYSR	SEK 76.00	-1.7%	-12.6%	SEK 1.3b	SEK 153.56	5.1	68.9%	n/a
300601	CN¥14.18	2.7%	-2.1%	CN¥15.8b	CN¥19.80	5.9	68.6%	0.6%
LCTX	US$1.48	-5.7%	215.0%	US$368.6m	US$4.50	25.3	68.6%	n/a
PGEN	US$4.16	5.6%	197.1%	US$1.5b	US$9.50	152.0	68.4%	n/a
A042520	₩31,300.00	-9.0%	363.7%	₩446.4b	n/a	4.5	68.1%	0%
NERV	US$5.51	4.4%	280.0%	US$238.4m	US$7.25	-0.8	67.9%	n/a
OCGN	US$1.76	-1.7%	154.9%	US$594.7m	US$11.57	134.8	67.8%	n/a
RARE	US$23.30	3.8%	-31.8%	US$2.3b	US$52.45	3.4	67.8%	n/a
SNDX	US$24.44	-2.8%	119.0%	US$2.2b	US$39.00	12.5	67.3%	n/a
QNCX	US$0.14	37.7%	-86.4%	US$7.6m	n/a	-0.1	67.2%	n/a
300294	CN¥18.85	1.3%	-35.0%	CN¥9.5b	CN¥31.50	84.3	67.0%	1.2%
INDP	US$2.11	31.9%	-84.3%	US$4.7m	US$10.00	1.5	66.9%	n/a
CANF	₪4.84	-4.8%	-91.0%	₪20.8m	n/a	16.9	66.8%	n/a
CLN	zł21.15	4.2%	-12.2%	zł1.1b	zł21.92	5.0	66.1%	0%
ATLN	US$2.78	-20.8%	-29.8%	US$220.4m	US$6.00	-2.2	65.8%	n/a
HLS	CA$4.55	3.4%	12.9%	CA$142.3m	CA$7.84	1.9	65.8%	0%
MRKR	US$1.75	32.6%	69.9%	US$29.2m	US$7.87	8.2	65.7%	n/a
KZIA	US$8.82	20.2%	129.1%	US$100.8m	US$19.16	75.0	65.7%	n/a
CRDL	CA$1.93	-2.5%	47.3%	CA$215.9m	CA$6.00	12.1	65.6%	n/a

Page 6 of 126